The US House has introduced a bill which if passed would reschedule cannabis, most likely to Schedule II. The bill would also redefine marijuana so as to exclude the non-psychoactive cannabidiol (CBD).
H.R. 715, aka “The Compassionate Access Act” was introduced by Rep. Griffith H. Morgan (R. VA). It’s important to remember that rescheduling cannabis would not repeal federal prohibition. All it would do is most likely result in cannabis being moved down to a Schedule II, which would make it easier to research it, hopefully putting to rest some of the outdated lies about it.
The Compassionate Access Act would also make it much easier for patients to obtain medical cannabis, because it would remove CBD from the definition of marijuana, which would be anything containing over 0.3 percent of THC (dry weight). Cannabidiol would essentially be removed from the Controlled Substances Act.
H.R. 715 would leave the actual rescheduling to the Secretary of Health and Human Services (HHS), as well as the National Academy of Science Institution of Medicine (NASIM), which would make the recommendation to the Drug Enforcement Administration (DEA) no later than 180 days after the initial bill is passed.
Before you get too excited, remember that the HHS Secretary is likely to be Tom Price. Price has been extremely vocal in his opposition towards medical cannabis. He’s voted against medical cannabis six different times. Still, there’s hope. If cannabis were rescheduled it would make it a lot easier to research it. Then we can begin to debunk every argument against it. I choose to remain optimistic, and will keep you updated on whether or not H.R. 715 passes.
Image Source: Vox
Do you think this bill has a good chance of passing? Will we finally see them reschedule cannabis? Share your thoughts in the comments!